Nomura Holdings’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-11,000
Closed -$56K 2347
2015
Q4
$56K Buy
+11,000
New +$63.8K ﹤0.01% 1756
2014
Q4
Sell
-429,948
Closed -$4.11M 3137
2014
Q3
$4.11M Sell
429,948
-40,054
-9% -$409K 0.01% 770
2014
Q2
$5.25M Sell
470,002
-225,850
-32% -$2.06M ﹤0.01% 658
2014
Q1
$6.98M Buy
695,852
+68,476
+11% +$989K ﹤0.01% 606
2013
Q4
$8.2M Sell
627,376
-108,986
-15% -$1.5M 0.04% 268
2013
Q3
$10.9M Sell
736,362
-40,720
-5% -$488K 0.07% 242
2013
Q2
$7.09M Buy
+777,082
New +$5.26M 0.06% 240

Other funds holding RPTP

Nomura Holdings's RPTP Position: Q1 2016 in Review

Nomura Holdings sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q1 2016, closing a stake of 11,000 shares — an estimated $56K sold.

Nomura Holdings first reported a position in RPTP in Q2 2013 and held it in 7 quarters. The position peaked at $10.9M in Q3 2013. 97 funds tracked by Wall St. Rank hold RPTP as of Q1 2016.

  • Nomura Holdings reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q1 2016 after selling out during the quarter.
  • Nomura Holdings sold 11,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q1 2016, an estimated $56K.
  • Nomura Holdings first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 7 quarters.
  • Nomura Holdings's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $10.9M in Q3 2013.
  • 97 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q1 2016.

Based on Nomura Holdings's 13F filing for Q1 2016, filed 16 May 2016.